海外の治験の状況「1」での検索結果
2901件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- A Randomized, Open, Multicenter Trial of Genexol-PM or Paclitaxel Injection combined with Cisplatin for first-line therapy of advanced Non-Small Cell Lung Cancer(NSCLC)
- Non-Small Cell Lung Cancer(NSCLC)
- China
- 2015-04-07
Recruiting
- Single-arm Study of Selumetinib in Combination With Docetaxel, in Advanced Gastric Adenocarcinoma Patients With Low/High MEK Signature, RAS Mutation or RAS Amplification as a Second-line Chemotherapy
- Gastric Adenocarcinoma;Gastric Adenocarcinoma;Gastric Adenocarcinoma;Gastric Adenocarcinoma
- Korea, Republic of
- 2015-01-15
Recruiting
- A clinical trial to study the effects of Velaglucerase Alfa Enzyme Replacement Therapy for the treatment of Type 3 Gaucher Disease
- Type 3 Gaucher Disease
- India, Tunisia
- 2012-05-18
Recruiting
- A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
- Breast Cancer
- Australia, Korea, Republic of, Spain, United Kingdom, United States
- 2017-11-01
Recruiting
- Green Therapy of Cancer 001 (GTC001): A prospective multicentre randomized controlled trial for the efficacy of minimally invasive cryoablation after first-line chemotherapy failure in advanced NSCLC based on the theory of 'treating heat with cold' of Traditional Chinese Medicine
- advanced non-small-cell lung carcinoma
- China
- 2018-06-02
Recruiting
- Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer
- Breast Cancer
- China
- 2011-11-25
Recruiting
- Biomarker for Gaucher Disease: BioGaucher
- Splenomegaly;Hepatomegaly
- Algeria, Brazil, Egypt, Germany, Greece, India, Serbia
- 2011-04-06
Recruiting
- Study of the Effect of Velaglucerase Alfa (VPRIV®) on Bone-related Pathology in Treatment-naïve Participants With Type 1 Gaucher Disease
- Gaucher Disease
- Israel, Spain, United Kingdom, United States
- 2015-10-09
Recruiting
- Phase II Study of Avelumab in Metastatic Gastronetro-pancreatic (GEP) Neuroendocrine Carcinoma (NEC, WHO Grade 3) as Second-line Treatment After Failing to Etoposide+Cisplatin: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes
- Neuroendocrine Carcinoma, Grade 3
- Korea, Republic of
- 2017-05-08
Recruiting
- Cetuximab in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel Plus Cisplatin Alone for the First-line Treatment of Metastatic Esophageal Squamous Cell Carcinoma
- Esophageal Cancer, Squamous Cell;Cetuximab Effect;Chemotherapy Effect
- China
- 2017-04-12
Recruiting
- A Phase 3 Randomized, Double-blind Study Of Pf- 06439535 Plus Paclitaxel-carboplatin And Bevacizumab Plus Paclitaxel -Carboplatin For The First-line Treatment Of Patients With Advanced Non-squamous Non-small Cell Lung Cancer.
- Non-small Cell Lung Cancer (NSCLC);C34 - Malignant neoplasm of bronchus and lung
- Australia, Brazil, Bulgaria, Chile, Croatia, Czech Republic, France, Germany, Greece, Hungary, India, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Poland, Romania, Russian Federation, Slovakia, South Africa, Spain, Taiwan, Province of China, Thailand, Turkey, Ukraine, United States
- 2015-10-13
Recruiting
- Nedaplatin (injection with Nedaplatin Combined with gemcitabine and cisplatin combined with gemcitabine in the first-line treatment of advanced lung carcinoma randomized controlled multicenter clinical study
- Advanced lung squamous cell carcinoma
- China
- 2016-06-04
Recruiting
- A research study to understand benefits and safety of Arimolomol a new drug for patients with Gaucher Disease
- Gaucher disease Type 1 and Type 3
- India
- 2017-12-29
Recruiting
- Evaluation for efficacy and toxicity of Nivolumab monotherapy for advanced non-small cell lung cancer after first-line treatment failure based on second-generation sequencing and liquid chip platform
- Non-small cell lung cancer
- China
- 2018-09-30
Recruiting
- Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform
- Lung Cancer Non-small Cell Stage IV;Lung Cancer Non-small Cell Stage IV
- China
- 2018-09-25
Recruiting
- Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease
- Primary Disease
- Israel
- 2018-08-06
Recruiting
- Phase II study of avelumab in metastatic gastronetro-pancreatic (GEP) neuroendocrine carcinoma (NEC, WHO grade 3) as second-line treatment after failing to etoposide+cisplatin: integration of genomic analysis to identify predictive molecular subtypes
- ;Neoplasms
- Korea, Republic of
- 2019-03-22
Recruiting
- A pilot study for evaluation of the safety and efficacy of eltrombopag plus pulsed dexamethasone as first line therapy for subjects with idiopathic thrombocytopenic purpura (ITP)
- immune thrombocytopenia (ITP)
- China
- 2019-02-01
Recruiting
- Multicenter, open, single-arm Clinical Study to Evaluate the Efficacy and Safety of Sintilimab Plus Chemotherapy (Cisplatin or Carboplatin+ Paclitaxel) as First-Line Treatment in Patients With Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma (R/M SCCHN)
- Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- China
- 2019-09-03
Recruiting
- Camrellizumab combined with stereotactic radiotherapy, apatinib mesylate and albumin-conjugated paclitaxel for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer with non-sensitive gene mutations: a prospective, single arm, single center, exploratory clinical study
- non-small cell lung cancer
- China
- 2019-10-25